Medical AI Alliance
← Company Index
Healthcare InfrastructureKOSDAQ 3590903 approvals6 trials

C&R Research Inc.

Contract research organization offering regulated and non-regulated clinical trial services along with the LeadTrial EDC and CTMS IT platforms.

As of 2026-10-10, C&R Research Inc. has 3 Korean MFDS device approvals, 13 PubMed-indexed papers on record (counted by the MAA Company Index from its own matching of public databases).

Price

Change

Market cap

Business overview

Source: DART corporate disclosure

Founded in 2020 and listed on KOSDAQ in 2020, the company is a contract research organization (CRO). It provides regulated clinical trials (Phase I-III) and non-regulated clinical trials (PMS, OS, Phase IV), and operates in-house IT solutions LeadTrial EDC, CTMS, and CsafeR, plus BOIM through its subsidiary Trial Informatics. It has been selected as a partner of the National OncoVenture and jointly conducts Phase 1 trials in Caucasian subjects with Seoul National University Hospital; 2025 revenue was KRW 64.982 billion.

Products & technology

  • Regulated clinical trials (Phase I-III)Clinical trial services for new and improved drug development
  • Non-regulated clinical trials (PMS, OS, Phase IV)Post-marketing surveillance and observational study services
  • LeadTrial EDCElectronic data capture (EDC) IT solution for clinical trials
  • CTMSClinical trial management system
  • CsafeRClinical trial safety management IT solution

Regulatory approvals

data.go.kr

3 Korean MFDS device approvals · 2021

  • MFDSGlove, patient examinationRevoked2021-07-13
    Product approval · Class 1수신 21-1313 호
  • MFDSGlove, patient examinationRevoked2021-07-13
    Product approval · Class 1수신 21-1312 호
  • MFDSGlove, patient examinationRevoked2021-07-13
    Product approval · Class 1수신 21-1311 호

Clinical trials

data.go.kr

6 MFDS clinical trial authorisations · 2014–2025 (Phase 3 2 · Phase 2 1 · Phase 1 1 · Phase 1/2 1 · Phase 2a 1)

  • Phase 2Rezafungin2025-04-22

    8 trial sites

  • Phase 1ODC-IL22025-03-17

    2 trial sites

  • Phase 1/2SLC-30102022-11-09

    8 trial sites

  • Phase 3Entinostat2017-09-29

    5 trial sites

  • Phase 2aBL-80402017-03-09

    1 trial site

  • Phase 3캐싸일라주 퍼제타주 허셉틴주 카보플라틴 도세탁셀2014-07-09

    6 trial sites

R&D and key agreements

Source: DART corporate disclosure

임상시험 개선 Platform (New Paradigm) · 연구개발 진행 · R&D on clinical trial improvement platforms conducted via in-house research institute established 2019; BOIM solution transferred to subsidiary Trial Informatics in 2024

Key disclosures

KRX KIND via OpenDART

Publications

PubMed · affiliation-matched
Show 3 more publications

Patents

KIPRIS · applicant-matched

AI reads

MAA server logs · IP-verified
69
Times AI engines pulled C&R Research Inc.'s records

Pulled records become part of each AI's index and keep feeding its answers. When an AI cites from that index, nothing reaches our server — so actual citations are uncounted here and exceed this number.

0
Fetched fresh mid-answer

Times an AI needed something not yet in its index and fetched this page fresh while answering. Citations served from the index leave no trace here.

69
Index crawls

Collected as raw material for future answers.

0
Direct AI-tool queries (MCP)

Queries from users who connected this index to their own AI.

12
live 0
Last 7 days
57
live 0
Last 30 days
69
live 0
All time
  • OpenAIOAI-SearchBot56
  • GoogleGoogleOther8
  • PerplexityPerplexityBot3
  • AnthropicClaudeBot2

Measured since Aug 27, 2026 · 4 AI engines · last read Oct 9, 2026

User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS. MCP queries are actual calls to this index's tool endpoint.

Connect this index to your AI tool →

Connect this company index directly to your AI

Connect it to ChatGPT or Claude, and your AI queries the full record — profiles, financials, stock data, regulatory approvals, clinical trials, publications and patents — for C&R Research Inc. and every listed Korean medical, bio and AI company.

How to connect (MCP)
Not yet compiled: business overview. Send us materials and we will add them

Companies approved for the same productsHealthcare Infrastructure

Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.

Alpha AI Co.,Ltd.1 shared

Alpha AI, founded in 1995 and KOSDAQ-listed in 2000, manufactures biocompatible metal implants and surgical instruments.

Billions Co.,Ltd.1 shared

Founded in 1973, KOSDAQ-listed in 2001, Billions makes medical rubber products like condoms and runs an entertainment business.

DAIHAN SCIENTIFIC CO., Ltd1 shared

KOSDAQ-listed lab equipment company manufacturing and distributing ultra-low temperature freezers, centrifuges, and autoclaves.

Hancom Lifecare Inc.1 shared

Hancom Lifecare, founded in 1971 and KOSPI-listed in 2021, manufactures personal protective equipment (PPE).

HLB Life Science CO.,LTD.1 shared

Founded in 1998 and listed on KOSDAQ in 2008, HLB Life Science operates four business divisions: medicare, bio-development, medical devices, and energy.

NANOOMTECH Co., Ltd.1 shared

A KONEX-listed medical device maker specializing in automated external defibrillators, including the AI-based ReHeart NT-381.AI model.

SEWOONMEDICAL CO,. LTD.1 shared

Founded in 1982 and KOSDAQ-listed in 2008, Sewoon Medical manufactures medical aspirators and catheters/tubes.

SHINHUNG CO.,LTD1 shared

Founded in 1964 and KOSPI-listed in 1991, Shinhung manufactures and distributes dental equipment and materials.

CJ CHEILJEDANG CORP.100

CJ CheilJedang, founded and KOSPI-listed in 2007, operates food, BIO, and logistics businesses as a CJ Group intermediate holding company.

Kwangdong Healthbio Co., Ltd.100

Supplies red ginseng, probiotics, and other health functional foods to 300+ clients via OEM/ODM.

Cellromax Science Co., Ltd.100

Founded in 2014 and listed on KOSDAQ in 2024, Cellromax Science is a health functional food company built on a nationwide pharmacy network.

KolmarBNH Co., Ltd100

Founded and listed on KOSDAQ in 2014, KolmarBNH develops health functional food and cosmetics materials and provides ODM/OEM manufacturing.

Sources and updates

Counts on this page are not company-reported figures. MAA matched records from DART, the Korean MFDS, the US FDA, ClinicalTrials.gov, PubMed and KIPRIS to this company itself, by business registration number or registered name, never by name similarity. They may differ from figures the company publishes.

Company basics
Korea Exchange · DART
Business content
Compiled from disclosure filings
Approvals & clinical trials
Korean MFDS (data.go.kr) · US FDA openFDA — updated weekly
Key disclosures
KRX KIND via OpenDART exchange filings — updated daily
Global clinical trials
ClinicalTrials.gov (US NIH) — sponsor-matched, updated weekly
Financials
DART corporate disclosure filings — annual
Publications
PubMed (US National Library of Medicine) — affiliation-matched, updated daily
Patents
KIPRIS (Korea Institute of Patent Information) — applicant-matched, updated monthly
AI reads
Our server logs, IP-verified every 6 hours
AI visibility
Measured 2026-10-01

This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.

Request a correction or addition